In the wake of the above, it must also be taken into account that an enhanced tumor aggressiveness is influenced by the presence of gene polymorphisms (specifically single‐nucleotide variations) of IL‐1β and IL‐1 type II receptor, an endogenous inhibitor of IL‐1β signaling.16 This evidence concerns the gene IL1B and neoplasm.